• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

How Gene Editing is Changing Otolaryngology

by Nikki Kean • December 6, 2017

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

Dr. Welling echoed concerns over the potential downstream risks of the procedure. “If we go off target, it could take decades for the long-term side effects [of gene editing] to unfold,” he warned.

You Might Also Like

  • Newly Identified Gene May Be Linked to Progressive Sensorineural Hearing Loss
  • Gene Therapy: A Promising Role in Otolaryngology
  • Otolaryngology Research Increasingly Supports Genetic Screening to Evaluate Pediatric Hearing Loss
  • First Two Patients Respond to Gene Therapy in Melanoma Study
Explore This Issue
December 2017

And then he pointed to an even more chilling scenario: “I do believe there will be lot of upsides to this technology, but it is also very accessible [to people with ill intent],” Dr. Welling said. “I know that is one of the concerns the intelligence community [has]—that CRISPR could produce a biologic weapon of mass destruction.”

Financial disclosures: Dr. Staecker disclosed that he is on the surgical advisory board of MedEl. None of the other participants have any financial conflicts to disclose.


Nikki Kean is a freelance medical writer based in New Jersey.

Key Points

  • Dominant deafness genes cannot be corrected with gene replacement strategies, so researchers are turning to gene editing to correct those types of hearing loss.
  • Many practical details regarding gene editing still need to be determined; any treatment for hearing loss would have to be performed during the earliest stages of fetal development.
  • Many bioethicists worry that the rapid pace of gene-editing innovation has occurred without enough discussion about the ethics of the procedure.

What Gene Would You Target First?

  • G. Richard Holt, MD, MSE, MPH: I would say the mutation of GJB2, because it is the most common cause of prelingual deafness, for autosomal recessive and non-syndromic hearing losses. Once you start considering the syndromic hearing losses, it opens up so many more deformities and deficiencies of other organs that, while addressing them would be quite beneficial, it would also be much more difficult. Perhaps [it would be] better to first look at single gene mutations for hearing loss.
  • Lawrence R. Lustig, MD: I would say if we could fix one congenital deafness gene, it should be GJB2 (connexin 26), because that is the most common.
  • Hinrich Staecker, MD, PhD: I would target myosin VII, one of the Usher syndrome genes, because it is the most common dominant gene seen in a cochlear implant population (up to 4%) and presents in prenatal and post-natal forms, so it makes a good potential target.
  • D. Bradley Welling, MD, PhD: Not an easy question to answer. There have been a few animal models that have shown some improvement with the Usher IC gene. Patients with this defect develop hearing loss early.

Landmark Gene-Editing Study Called Into Question

The news that researchers had successfully removed a genetic defect in human embryos using the gene-editing tool CRISPR-Cas9 has recently been called into question. First reported in Nature (2017;548:13-14), the team cited a high success rate (72.4%) at correcting a mutation in the MYBPC3 gene, which causes hypertrophic cardiomyopathy.

Pages: 1 2 3 4 5 | Single Page

Filed Under: Departments, Home Slider, Special Reports Tagged With: clinical best practices, gene editing, gene replacement, gene replacement for hearing loss, hearing lossIssue: December 2017

You Might Also Like:

  • Newly Identified Gene May Be Linked to Progressive Sensorineural Hearing Loss
  • Gene Therapy: A Promising Role in Otolaryngology
  • Otolaryngology Research Increasingly Supports Genetic Screening to Evaluate Pediatric Hearing Loss
  • First Two Patients Respond to Gene Therapy in Melanoma Study

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Would you choose a concierge physician as your PCP?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Keeping Watch for Skin Cancers on the Head and Neck

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • 22 Symptoms Common to Patients with Superior Canal Dehiscence Syndrome

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Excitement Around Gene Therapy for Hearing Restoration
    • “Small” Acts of Kindness
    • How To: Endoscopic Total Maxillectomy Without Facial Skin Incision
    • Science Communities Must Speak Out When Policies Threaten Health and Safety
    • Observation Most Cost-Effective in Addressing AECRS in Absence of Bacterial Infection

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939